Form D · Biotechnology
Cellerant Therapeutics Inc
San Carlos, CA · CIK 0001293600
Offering snapshot reported Feb 12, 2019 · SEC filing
- Reported sold
- $6.55M Offering amount: $10M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 4, 2016 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$2,025,000 → $6,550,000
- Reported investors7 → 10
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 12, 2019 | Amendment | $6,550,000 | $4,525,000vs Apr 13, 2016 | 10 | SEC filing |
| Apr 13, 2016 | Initial | $2,025,000 | No comparison | 7 | SEC filing |
| Jan 22, 2014 | Initial | $2,190,000 | No comparison | 5 | SEC filing |
| Sep 24, 2012 | Initial | $2,094,341 | No comparison | 3 | SEC filing |
| Aug 31, 2011 | Initial | $800,000 | No comparison | 2 | SEC filing |
| Apr 21, 2011 | Amendment | $2,022,678 | $1,012,678vs Dec 29, 2010 | 4 | SEC filing |
| Dec 29, 2010 | Initial | $1,010,000 | No comparison | 4 | SEC filing |
| Jun 30, 2010 | Amendment | $4,537,908 | $2,287,908vs Feb 9, 2010 | 5 | SEC filing |
| Feb 9, 2010 | Initial | $2,250,000 | No comparison | 3 | SEC filing |
| Oct 23, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 11, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 23, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 5, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06c
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-261165
Source: Form D, filed Feb 12, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Chyette | Director |
| Stephen Greenberg | Director |
| Robby Hogle | Director |
| Ramkumar Mandalam | Director, Executive |
| Antoun Nabhan | Director |
| Richard G. Rathmann | Director |
| Gisela Schwab | Director |
| Lowell Sears | Director |
| Rodney Young | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1561 Industrial Road
San Carlos, CA, 94070
San Carlos, CA, 94070